常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.93/-4.13
|
|
企業價值
3.75B
|
| 資產負債 |
|
每股賬面淨值
7.62
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
107.94M
|
|
每股收益
0.56
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors. |

64.975 
